Edition:
India

Zynerba Pharmaceuticals Inc (ZYNE.OQ)

ZYNE.OQ on NASDAQ Stock Exchange Global Market

10.42USD
19 Jul 2018
Change (% chg)

$0.00 (+0.00%)
Prev Close
$10.42
Open
--
Day's High
--
Day's Low
--
Volume
22,707
Avg. Vol
81,928
52-wk High
$19.68
52-wk Low
$5.42

Revenue & Earnings Per Share

    Revenue* Earnings Per Share**
FY 2018 Mar '18 0.00 -0.914
FY 2017 Dec '17 0.00 -0.605
Sep '17 0.00 -0.635
Jun '17 0.00 -0.638
Mar '17 0.00 -0.602
FY 2016 Dec '16 0.00 -0.712
Sep '16 0.00 -0.671
Jun '16 0.00 -0.703
Mar '16 0.01 -0.485
 
*Note: Units in Millions ofU.S. Dollars
**Note: Units in U.S. Dollars

Consensus Estimates Analysis

  # of Estimates Mean High Low 1 Year Ago
SALES (in millions)
Quarter Ending Sep-18 6 0.00 0.00 0.00 0.00
Quarter Ending Dec-18 6 0.00 0.00 0.00 0.00
Year Ending Dec-18 6 0.00 0.00 0.00 0.38
Year Ending Dec-19 5 0.00 0.00 0.00 3.10
Earnings (per share)
Quarter Ending Sep-18 6 -0.74 -0.59 -0.96 -0.72
Quarter Ending Dec-18 6 -0.73 -0.57 -0.90 -0.73
Year Ending Dec-18 6 -3.11 -2.73 -3.57 -2.73
Year Ending Dec-19 5 -3.05 -2.57 -4.34 -2.69
Sales and Profit Figures in US Dollar (USD);

Valuation Ratios

Dividends

Growth Rates

Financial Strength

Profitability Ratios

Efficiency

Management Effectiveness

  1 Year 3 Year 5 Year
Sales % -97.40 -80.27 --
EPS (TTM) % 8.42 -- --
Dividend % -- -- --
Note: Units in Millions of US Dollars

Performance for Zynerba Pharmaceuticals Inc

Period %
Actual
% vs.
S&P 500
Rank In
Industry
Industry
Rank
4 Week 52.61 47.34 99 --
13 Week -45.33 -47.99 9 --
26 Week -56.27 -59.59 16 --
52 Week -26.93 -38.07 62 --
YTD -38.04 -45.58 35 --
Note:: Rank is a percentile that ranges from 0 to 99, with 99 = best.

Institutional Holders

% Shares Owned: 24.82%
# of Holders: 86
Total Shares Held: 3,365,910
3 Mo. Net Change: 248,403
# New Positions: 2
# Closed Positions: 2
# Increased Positions: 4
# Reduced Positions: 4
# Net Buyers: 0
NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.